Rezolute (RZLT) Amortization of Deferred Charges (2012 - 2019)
Rezolute recorded quarterly Amortization of Deferred Charges of $472000.0 in Q1 2019, down 46.24% quarter-over-quarter from $878000.0 in Q4 2018.
Rezolute's Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $472000.0 for Q1 2019.
- In Q1 2019, Amortization of Deferred Charges changed N/A year-over-year to $472000.0; the TTM figure through Dec 2019 stood at $472000.0 (down 70.15% YoY), while the FY2019 annual figure was $2.1 million, changed N/A from the prior year.
- Amortization of Deferred Charges came in at $472000.0 for Q1 2019 at Rezolute, down from $878000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $878000.0 in Q4 2018 to a low of $472000.0 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 472,000.00 |
| Mar 31, 2019 | 472,000.00 |
| Dec 31, 2018 | 878,000.00 |
| Dec 31, 2018 | 878,000.00 |
| Sep 30, 2018 | 703,000.00 |
| Sep 30, 2018 | 703,000.00 |
| Mar 31, 2014 | 266,693.00 |
| Mar 31, 2014 | 266,693.00 |
| Dec 31, 2013 | 74,136.00 |
| Dec 31, 2013 | 74,136.00 |
| Sep 30, 2013 | 75,508.00 |
| Sep 30, 2013 | 75,508.00 |
| Jun 30, 2013 | 90,585.00 |
| Jun 30, 2013 | 90,585.00 |
| Mar 31, 2013 | 101,082.00 |
| Mar 31, 2013 | 101,082.00 |
| Dec 31, 2012 | 42,643.00 |
| Dec 31, 2012 | 42,643.00 |
| Sep 30, 2012 | 44,786.00 |
| Sep 30, 2012 | 44,786.00 |
| Jun 30, 2012 | 59,021.00 |
| Jun 30, 2012 | 59,021.00 |
| Mar 31, 2012 | 47,833.00 |
| Mar 31, 2012 | 47,833.00 |